JGMIX | VEXRX | JGMIX / VEXRX | |
Total Expense Ratio | 1.16 | 0.34 | 341% |
Annual Report Gross Expense Ratio | 1.16 | 0.34 | 341% |
Fund Existence | 16 years | 23 years | - |
Gain YTD | -10.494 | -13.374 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 50000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.55B | 19.8B | 28% |
Annual Yield % from dividends | 0.00 | 0.56 | - |
Returns for 1 year | -9.27 | -11.24 | 82% |
Returns for 3 years | -20.81 | -8.96 | 232% |
Returns for 5 years | -8.25 | 17.63 | -47% |
Returns for 10 years | -11.33 | 0.85 | -1,334% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 80.89 | 1.79 | +2.26% |
SPDR® S&P Biotech ETF | |||
FEP | 42.41 | 0.74 | +1.78% |
First Trust Europe AlphaDEX® ETF | |||
SBIO | 28.51 | 0.49 | +1.75% |
ALPS Medical Breakthroughs ETF | |||
BCDF | 28.98 | 0.44 | +1.54% |
Horizon Kinetics Blockchain Dev ETF | |||
CHI | 9.92 | 0.14 | +1.43% |
Calamos Convertible Opportunities and Income Fund |